The development of Cop 1 (Copaxone), an innovative drug for the treatment of multiple sclerosis: personal reflections

Immunol Lett. 1996 Apr;50(1-2):1-15. doi: 10.1016/0165-2478(96)02506-0.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Clinical Trials as Topic
  • Double-Blind Method
  • Encephalomyelitis, Autoimmune, Experimental / drug therapy
  • Humans
  • Multiple Sclerosis / drug therapy*
  • Peptides / adverse effects
  • Peptides / chemical synthesis
  • Peptides / immunology
  • Peptides / metabolism
  • Peptides / therapeutic use*

Substances

  • Peptides
  • (T,G)-A-L